Showing results (1001-1010 of 1,329) with videos related to
Sort By:
Pageof 133
COPD|May 5, 2015
Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitusAndrew W Hitchings, John R H Archer, Shelley A Srivastava, et al.COPD|July 22, 2020
Inspiratory Muscle Training Potentiates the Beneficial Effects of Proportional Assisted Ventilation on Exertional Dyspnea and Exercise Tolerance in COPD: A Proof-of-Concept Randomized and Controlled TrialRodrigo Koch, Tiago Rodrigues de Lemos Augusto, Alessandro Gomes Ramos, et al.COPD|May 11, 2023
Do Functional Tests Estimate Physical Activity in COPD?Natielly Soares Correia, Joice Mara de Oliveira, Lorena Paltanin Schneider, et al.COPD|October 22, 2019
Physiological and Symptomatic Responses to Arm versus Leg Activities in People with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-AnalysisErik Frykholm, Vanessa Pereira Lima, Hanna-Vega Selander, et al.COPD|March 21, 2018
Management of COPD in End-of-Life Care by Spanish PulmonologistsPatricia Sobradillo Ecenarro, Marta Inchausti Iguiñiz, Sandra Pedrero Tejada, et al.COPD|October 7, 2017
Bioequivalence of a Liquid Formulation of Alpha1-Proteinase Inhibitor Compared with Prolastin®-C (Lyophilized Alpha1-PI) in Alpha1-Antitrypsin DeficiencyAlan F Barker, Michael A Campos, Mark L Brantly, et al.COPD|January 31, 2018
The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening CohortChristopher L Sanders, Amy Ponte, Friedrich KueppersCOPD|February 23, 2018
The Glittre-ADL Test Cut-Off Point to Discriminate Abnormal Functional Capacity in Patients with COPDAline Almeida Gulart, Anelise Bauer Munari, Suelen Roberta Klein, et al.COPD|December 7, 2006
An inhaled matrix metalloprotease inhibitor prevents cigarette smoke-induced emphysema in the mousePhilip A Pemberton, John S Cantwell, Karen M Kim, et al.Pageof 133